Equity
€220,273 ▲ 38.4%
Equity rose in 2025 from €159,123 to €220,273.
SV Pharma
Lifetime
4 annual accounts with figures on one time axispeak €8,929 (2022)
€6,407▲ €25,821
lowest -€622 (2022)
€61,150▲ 61.3%
peak €220,273 (2025)
€220,273▲ 38.4%
€594,236▼ 4.0%
peak 0 FTE (2023)
0 FTE
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
17-01-202614 days before the deadline
2025financial year
Gross margin from -€19,414 to €6,407Result from €37,913 to €61,150Equity from €159,123 to €220,273
Key points
from the 2025 annual accountsTurnover
≈ €31,000 estimated
The accounts state no turnover.
Debts
€594,236 73% of the balance sheet
Financial debts 36%Suppliers 1%Taxes and wages 2%Other 61%
Of this, €57,436 falls due within a year.
Investments
€12,386 5.5 × depreciation
Green is investment, beige is depreciation. Machinery stands 614.1% higher than in 2024.
Liquidity
1.25 was 0.79 in 2024
Short-term debts rose from €44,619 to €57,436.
Position in the sector
€220,273
Less equity than 90% of companies in financial services. Sector median €9.7m · 2,069 companies.
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 30-04-2021
Director, since 30-04-2021
- annual accounts 30-06-2025
- annual accounts 30-06-2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0767715111
Incorporation
Founders: and · 100 shares · Appointments: (director) and (director) · published on 04-05-2021 · Gazette deed
First establishment
Avenue Reine Astrid 24, Ottignies-Louvain-la-Neuve
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SV Pharma Ottignies-Louvain-la-Neuve | €0.8m | €6,407 | 27.0% | 0 |
| Falcon rentals Antwerp | €1.2m | €6,405 | 14.9% | 0 |
| United Experts Group Beringen | €0.5m | €10,685 | 28.6% | 0 |
| ZIRKA INVEST Grimbergen | €0.8m | €11,945 | 99.9% | 0 |
| Sharepeople Buggenhout | €1.0m | €13,051 | 45.4% | 0 |
| DAZY MANAGEMENT Florenville | €0.4m | €7,628 | 42.1% | 0 |
| PHENIKS Zottegem | €0.5m | €11,661 | 55.6% | 0 |
These companies have the same main activity as SV Pharma: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €358,000 and €1.2m, founded between 2019 and 2022.
Official details
Source: KBO- Status
- Active since 30-04-2021Normal situation
- Activity
- Activities of holding companiesNACE 64210and 1 other
- Establishment unit
- 2.316.654.5621340 Ottignies-Louvain-la-Neuve, since 30-04-2021
- Financial year end
- 30 June
- Peppol
- Reachable since 13-05-2026
Annual accounts to 30-06-2025
- €814,509▲ 4.6%
- Filing
- Filed on 17-01-2026, 14 days before the end of the filing period
Insights on SV Pharma
Solvency rose in 2025 from 20.4% to 27.0% because of the retained profit.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SV Pharma
- What is the company number of SV Pharma?
- The company number of SV Pharma is 0767.715.111. The VAT number is the same number with BE in front: BE 0767.715.111.
- Where is SV Pharma based?
- The registered office is at Avenue Reine Astrid 24, 1340 Ottignies-Louvain-la-Neuve.Company details
- What does SV Pharma do?
- According to the KBO register, the main activity is activities of holding companies (NACE 64210).
- What is the legal form of SV Pharma?
- SV Pharma is a private limited company (BV).
- When was SV Pharma founded?
- SV Pharma was founded on 30-04-2021.
- Is SV Pharma still active?
- Yes, SV Pharma is an active enterprise in the KBO register.
- What is the turnover of SV Pharma?
- The turnover in financial year 2025 is ≈ €31,000. This figure is estimated from the gross margin of €6,407 and 54 comparable companies (NACE 64210). It probably lies between €16,000 and €54,000. It is a rough estimate.Financials
- Is SV Pharma profitable?
- In financial year 2025, SV Pharma made a profit of €61,150.
- Where can I find the annual accounts of SV Pharma?
- SV Pharma filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SV Pharma due?
- SV Pharma must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See this company's board, registered office and name on a given date.Company as of a date
See how customers, suppliers and banks see your own company and what to improve first.